PNMA2 and small intestinal neuroendocrine tumor G1: The field continues to search for improved biomarkers, actively investigating new candidates, such as paraneoplastic Ma antigen 2 (PNMA2) which is detected in small intestine carcinoid tumors and used to assess the risk of recurrence [32].